PMID- 26179854
OWN - NLM
STAT- MEDLINE
DCOM- 20170824
LR  - 20181202
IS  - 1989-4805 (Electronic)
IS  - 1889-1837 (Linking)
VI  - 32
IP  - 1
DP  - 2015 Jan-Mar
TI  - [The association of hyperinsulinemia with cardiovascular risk and cancer poses 
      new challenges in the treatment of the insulin resistance type 2 diabetes 
      patient].
PG  - 21-6
LID - S1889-1837(14)00061-0 [pii]
LID - 10.1016/j.hipert.2014.06.001 [doi]
AB  - Hyperinsulinemia has been associated with cardiovascular risk, both independently 
      and by facilitating the development of other cardiovascular risk factors. It has 
      also been associated by different routes with increased cancer risk. Thus, this 
      makes it a priority to identify and treat the hyperinsulinemic patient early in 
      order to delay or prevent cardiovascular risk and the development of type 2 
      diabetes mellitus (T2DM) and certain types of cancer. A new strategy is needed 
      for the treatment of hyperglycemia in these patients, whose primary objective 
      would be to achieve weight loss, reduce insulin resistance and thereby 
      hyperinsulinemia. That is, prescribing insulin secretors and insulin should be 
      used with caution in these patients.
CI  - Copyright (c) 2014 SEHLELHA. Published by Elsevier Espana. All rights reserved.
FAU - Nubiola, Andreu
AU  - Nubiola A
AD  - Unitat d́Endocrinologia, Servei de Medicina Interna, Hospital Universitari de 
      LEsperit Sant, Santa Coloma de Gramenet, Barcelona, Espana. Electronic address: 
      anubiola@hes.scs.es.
FAU - Ferrer, Marga
AU  - Ferrer M
AD  - Unitat d́Endocrinologia, Servei de Medicina Interna, Hospital Universitari de 
      LEsperit Sant, Santa Coloma de Gramenet, Barcelona, Espana.
FAU - Remolins, Imma
AU  - Remolins I
AD  - Unitat de Nutricio, PAMEM (IMAS), Barcelona, Espana.
LA  - spa
PT  - Journal Article
TT  - La asociacion de hiperinsulinemia con riesgo cardiovascular y cancer plantea 
      nuevos retos en el abordaje del paciente con diabetes tipo 2, 
      insulinorresistente.
DEP - 20140715
PL  - Spain
TA  - Hipertens Riesgo Vasc
JT  - Hipertension y riesgo vascular
JID - 101510649
SB  - IM
MH  - *Cardiovascular Diseases
MH  - *Diabetes Mellitus, Type 2
MH  - Humans
MH  - Hyperinsulinism
MH  - *Insulin Resistance
MH  - Neoplasms
MH  - Risk Factors
OTO - NOTNLM
OT  - Cancer
OT  - Cardiovascular
OT  - Cancer
OT  - Diabetes tipo 2
OT  - Hiperinsulinemia
OT  - Hyperinsulinemia
OT  - Insulin resistance
OT  - Insulinorresistencia
OT  - Type 2 diabetes
EDAT- 2015/07/17 06:00
MHDA- 2017/08/25 06:00
CRDT- 2015/07/17 06:00
PHST- 2014/06/12 00:00 [received]
PHST- 2014/06/14 00:00 [revised]
PHST- 2014/06/16 00:00 [accepted]
PHST- 2015/07/17 06:00 [entrez]
PHST- 2015/07/17 06:00 [pubmed]
PHST- 2017/08/25 06:00 [medline]
AID - S1889-1837(14)00061-0 [pii]
AID - 10.1016/j.hipert.2014.06.001 [doi]
PST - ppublish
SO  - Hipertens Riesgo Vasc. 2015 Jan-Mar;32(1):21-6. doi: 
      10.1016/j.hipert.2014.06.001. Epub 2014 Jul 15.